Statins and risk of cancer: A retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans

Journal of the American College of Cardiology

Volumn 58, Issue 5, 2011, Pages 530-537

  Marelli, Claudio ^a   Gunnarsson, Candace ^a   Ross, Susan ^a   Haas, Sara ^a   Stroup, Donna F ^a   Cload, Paul ^b   Clopton, Paul ^c   DeMaria, Anthony N ^d  

^a S2 Statistical Solutions Inc   (United States)

^b GE HEALTHCARE   (United Kingdom)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cancer; drug; risk; safety; statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DRUG UTILIZATION; DYSLIPIDEMIA; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; REVIEW; UNITED STATES;

EID: 79960589702     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.04.015     Document Type: Article

References (40)

1. E.S. Spatz, M.E. Canavan, and M.M. Desai From here to JUPITER: identifying new patients for statin therapy using data from the 19992004 National Health and Nutrition Survey Circ Cardiovasc Qual Outcomes 2 2009 41 48
2. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
3. M.J. Pletchter, I. Lazar, and K. Bibbins-Domingo Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering Ann Intern Med 150 2009 243 254
4. O. Ben-Yehuda, and A.N. DeMaria Low LDL-C levels and cancer reassuring but still not definitive J Am Coll Cardiol 52 2008 1150 1151
5. C.M. Rembold Age predicts cancer incidence better than statin-induced low-density lipoprotein level J Am Coll Cardiol 51 2008 90 91
6. D. Steinberg Statin treatment does not cause cancer J Am Coll Cardiol 52 2008 1148 1149
7. T.E. Strandberg Low low-density lipoprotein cholesterol and cancer risk J Am Coll Cardiol 51 2008 91 92 author reply 92
8. A.A. Alsheikh-Ali, P.V. Maddukuri, H. Han, and R.H. Karas Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer insights from large randomized statin trials J Am Coll Cardiol 50 2007 409 418 (Pubitemid 47096680)
9. A.N. DeMaria, and O. Ben-Yehuda Low-density lipoprotein reduction and cancer: not definitive but provocative J Am Coll Cardiol 50 2007 421 422
10. S. Bonovas, K. Filioussi, and N. Tsavaris Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials J Clin Oncol 24 2006 4808 4817 (Pubitemid 46655612)
11. L.M. Bjerre, and J. LeLorier Do statins cause cancer? A meta-analysis of large randomized clinical trials Am J Med 110 2001 716 723 (Pubitemid 32524321)
12. C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
13. S.D. Wiviott, C.P. Cannon, D.A. Morrow, K.K. Ray, M.A. Pfeffer, and E. Braunwald Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE ITTIMI 22 substudy J Am Coll Cardiol 46 2005 1411 1416 (Pubitemid 41446174)
14. M.R. Graaf, A.B. Beiderbeck, A.C. Egberts, D.J. Richel, and H.J. Guchelaar The risk of cancer in users of statins J Clin Oncol 22 2004 2388 2394 (Pubitemid 41115396)
15. J.A. Kaye, and H. Jick Statin use and cancer risk in the General Practice Research Database Br J Cancer 90 2004 635 637 (Pubitemid 38297203)
16. S. Friis, A.H. Poulsen, and S.P. Johnsen Cancer risk among statin users: a population-based cohort study Int J Cancer 114 2005 643 647 (Pubitemid 40349625)
17. K.M. Dale, C.I. Coleman, N.N. Henyan, J. Kluger, and C.M. White Statins and cancer risk: a meta-analysis JAMA 295 2006 74 80 (Pubitemid 43042692)
18. A. Alsheikh-Ali, T.A. Trikalinos, D.M. Kent, and R.H. Karas Statins, low-density lipoprotein cholesterol, and risk of cancer J Am Coll Cardiol 52 2008 1141 1147
19. A.B. Rossebo, T.R. Pedersen, and K. Borman Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
20. R. Peto, J. Emberson, and M. Landray Analyses of cancer data from three ezetimibe trials N Engl J Med 359 2008 1357 1366
21. A. Crawford, C. Christine, and C. Joseph Comparison of GE Centricity Electronic Medical Record Database and National Ambulatory Medical Care Survey Findings on the prevalence of major conditions in the United States Popul Health Manag 13 2010 139 150
22. M. Naghavi, E. Falk, and H.S. Hecht From vulnerable plaque to vulnerable patient - Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report Am J Cardiol 98 2006 2H 15H
23. R.B. D'Agostino, and D.B. Rubin Estimating and using propensity scores with partially missing data J Am Stat Assoc 95 2000 749 759
24. L.S. Parsons Reducing bias in a propensity matched-pair sample using greedy matching techniques Proceedings of the twenty-sixth annual SAS users group international conference 2001 SAS Institute Inc Cary, NC l214 l226
25. R.B. D'Agostino Jr Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group Stat Med 17 1998 2265 2281 (Pubitemid 28466823)
26. M.S. Katz Therapy insight: potential of statins for cancer chemoprevention and therapy Nature Clin Pract Oncol 2 2005 82 89 (Pubitemid 40790141)
27. V. Brower Of Cancer and cholesterol: studies elucidate anticancer mechanisms of statins J Natl Cancer Inst 95 2003 844 846 (Pubitemid 36833868)
28. K.K. Chan, A.M. Oza, and L.L. Siu The statins as anticancer agents Clin Cancer Res 9 2003 10 19 (Pubitemid 36109711)
29. Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins Lancet 366 2005 1267 1278
30. M.L. Taylor, B.J. Wells, and M.J. Smolak Statins and cancer: a meta-analysis of case-control studies Eur J Cancer Prev 17 2008 259 268 (Pubitemid 351549667)
31. FDA's Sentinel Initiative http://www.fda.gov/Safety/ FDAsSentinelInitiative/default.htm Accessed February 7, 2010
32. M.L. Berger, M. Bamdani, D. Atkins, and M.L. Johnson Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part I Value Health 12 2009 1044 1052
33. E. Cox, B.C. Martin, T. Van Staa, E. Garge, U. Siebert, and M.L. Johnson Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force ReportPart II Value Health 12 2009 1053 1061
34. M.L. Johnson, W. Crown, C.M. Bradley, C.R. Dormuth, and U. Siebert Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force ReportPart III Value Health 12 2009 1062 1073
35. P.R. Rosenbaum Sensitivity to hidden bias P.R. Rosenbaum, Observational Studies 2nd edition 2002 Springer-Verlag New York 110 124
36. R. Sikka, F. Xia, and R.E. Aubert Estimating medication persistency using administrative claims data Am J Manag Care 11 2005 449 457 (Pubitemid 41022729)
37. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
38. R.W. Sherwin, D.N. Wentworth, J.A. Cutler, S.B. Hulley, L.H. Kuller, and J. Stamler Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial JAMA 257 1987 943 948 (Pubitemid 17024387)
39. A. Schatzkin, R.N. Hoover, and P.R. Taylor Serum cholesterol and cancer in the NHANES I epidemiologic followup study National Health and Nutrition Examination Survey Lancet 2 1987 298 301 (Pubitemid 17104205)
40. D. Jacobs, H. Blackburn, and M. Higgins Report of the Conference on Low Blood Cholesterol: Mortality Associations Circulation 86 1992 1046 1060